Early research (Phase 1)Study completedNCT00006368
What this trial is testing
Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer
Who this might be right for
Brain and Central Nervous System TumorsBreast CancerGastrointestinal Carcinoid Tumor+5 more
Novartis Pharmaceuticals 60